JP2008518015A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518015A5
JP2008518015A5 JP2007539037A JP2007539037A JP2008518015A5 JP 2008518015 A5 JP2008518015 A5 JP 2008518015A5 JP 2007539037 A JP2007539037 A JP 2007539037A JP 2007539037 A JP2007539037 A JP 2007539037A JP 2008518015 A5 JP2008518015 A5 JP 2008518015A5
Authority
JP
Japan
Prior art keywords
compound according
compound
represented
following formula
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007539037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518015A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038348 external-priority patent/WO2006047507A2/en
Publication of JP2008518015A publication Critical patent/JP2008518015A/ja
Publication of JP2008518015A5 publication Critical patent/JP2008518015A5/ja
Withdrawn legal-status Critical Current

Links

JP2007539037A 2004-10-26 2005-10-25 ホスホネート置換キナーゼ阻害剤 Withdrawn JP2008518015A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US62309804P 2004-10-26 2004-10-26
US62294304P 2004-10-26 2004-10-26
US62281104P 2004-10-26 2004-10-26
US62288104P 2004-10-26 2004-10-26
US62294204P 2004-10-26 2004-10-26
US62299204P 2004-10-26 2004-10-26
US62296004P 2004-10-26 2004-10-26
PCT/US2005/038348 WO2006047507A2 (en) 2004-10-26 2005-10-25 Phosphonate substituted kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2008518015A JP2008518015A (ja) 2008-05-29
JP2008518015A5 true JP2008518015A5 (https=) 2008-11-13

Family

ID=36228375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007539037A Withdrawn JP2008518015A (ja) 2004-10-26 2005-10-25 ホスホネート置換キナーゼ阻害剤

Country Status (5)

Country Link
EP (1) EP1809299A2 (https=)
JP (1) JP2008518015A (https=)
AU (1) AU2005299504A1 (https=)
CA (1) CA2585281A1 (https=)
WO (1) WO2006047507A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749223B (zh) * 2015-11-25 2019-12-20 中国科学院广州生物医药与健康研究院 酪氨酸激酶抑制剂及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235834A1 (en) * 2003-03-25 2004-11-25 Farmer Luc J. Thiazoles useful as inhibitors of protein kinases
US20060069101A1 (en) * 2004-09-27 2006-03-30 Kim Kyoung S Prodrugs of protein tyrosine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2007529421A5 (https=)
JP4959900B2 (ja) 抗ウイルスピリミジンヌクレオシド類
ES2547916T3 (es) Terapia de combinación de inhibidores de mTOR/JAK
AU2014372166B2 (en) Pharmaceutical combinations
KR101762999B1 (ko) 종양 치료제
TWI633887B (zh) 用於預防及／或治療多囊性腎臟病之藥物
JP2014518266A5 (https=)
JP2013512903A5 (https=)
JP2019515908A5 (https=)
JP2008514732A5 (https=)
ES2698363T3 (es) Composiciones de oxprenolol para tratar el cáncer
WO2014082578A1 (zh) 杂芳基炔烃化合物及其应用
US20200352937A1 (en) Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from bcl2 inhibitors, bcl2/bclxl inhibitors, and bclxl inhibitors and methods of use
JP2016525104A5 (https=)
KR101401220B1 (ko) 방사선 치료 증강제
JP2013501808A (ja) アポトーシスを促進し、かつ転移を阻害する方法
JP2011518168A5 (https=)
TW200927127A (en) Agent for overcoming resistance to anti-cancer agent
ES3037417T3 (en) Purine derivatives as sik-3 inhibitors
JPWO2021007245A5 (https=)
JP2016530208A5 (https=)
JP2008518015A5 (https=)
RU2016110546A (ru) Комбинированная лекарственная терапия
JP7493503B2 (ja) Ｍｃｌ－１阻害剤とミドスタウリンとの組み合わせ、その使用及び医薬組成物
ES2350803T3 (es) Procedimiento de administración de un compuesto antitumoral.